Natural Product: NPC30397

Natural Product IDNPC30397
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
3-O-Beta-D-Glucopyranosyl Quinovic Acid28-O-Beta-D-Glucopyranosyl Ester
IUPAC Name (1S,2R,4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-1,2,6b,9,9,12a-hexamethyl-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-6a-carboxylic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL501302
PubChem CID 14194010
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LDCLXZSKVDYDBF-DTJUAWDLSA-N
Standard InCHI InChI=1S/C42H66O15/c1-19-9-14-41(37(53)57-35-33(50)31(48)29(46)23(18-44)55-35)15-16-42(36(51)52)21(27(41)20(19)2)7-8-25-39(5)12-11-26(38(3,4)24(39)10-13-40(25,42)6)56-34-32(49)30(47)28(45)22(17-43)54-34/h7,19-20,22-35,43-50H,8-18H2,1-6H3,(H,51,52)/t19-,20+,22-,23-,24+,25-,26+,27+,28-,29-,30+,31+,32-,33-,34+,35+,39+,40-,41+,42-/m1/s1
SMILES OC[C@H]1O[C@@H](O[C@H]2CC[C@]3([C@H](C2(C)C)CC[C@@]2([C@@H]3CC=C3[C@]2(CC[C@@]2([C@H]3[C@@H](C)[C@H](C)CC2)C(=O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)C(=O)O)C)C)[C@@H]([C@H]([C@@H]1O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   810.44 Volume:   799.037
?
Van der Waals volume.
Dense:   1.014 LogP:   0.822
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.961
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.199
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   40.0
TPSA:   253.13
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   9.0 Rings:   7.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.1 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.916 Fsp3:   0.905
MCE-18:   151.25
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.851 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.029
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.161 Promiscuous compounds:   0.207

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.141 MDCK Permeability:   -5.044
Pgp-inhibitor:   0.0 Pgp-substrate:   0.065
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.781
20% Bioavailability (F20%):   0.255 30% Bioavailability (F30%):   0.998
50% Bioavailability (F50%):   0.961

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.197
Plasma Protein Binding (PPB):   64.623% Volume Distribution (VD):   -0.512
Fu: 29.713%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.028 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.001
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.432 Half-life (T1/2):  3.024

ADMET: Toxicity

hERG Blockers:  0.004 hERG Blockers (10um):  0.002
Human Hepatotoxicity (H-HT):  0.841 Drug-induced Liver Injury (DILI):  0.977
AMES Toxicity:  0.942 Rat Oral Acute Toxicity:  0.003
Maximum Recommended Daily Dose:  0.003 Skin Sensitization:  1.0
Carcinogencity:  0.419 Eye Corrosion:  0.0
Eye Irritation:  0.001 Respiratory Toxicity:  0.004
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.998
Hematotoxicity:  0.612 Drug-induced Nephrotoxicity:  0.991
Genotoxicity:  0.9 RPMI-8226 Immunitoxicity:  0.05
A549 Cytotoxicity:  0.258 Hek293 Cytotoxicity:  0.103
BCF:   0.581
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.358
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.856
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.95
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26547 Uncaria tomentosa Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[1919590]
NPO25311 Guettarda platypoda Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[2553871]
NPO26547 Uncaria tomentosa Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[2553871]
NPO25311 Guettarda platypoda Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO26547 Uncaria tomentosa Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO22818 Acritopappus confertus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO26547 Uncaria tomentosa Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22560 Strychnos parvifolia Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26547 Uncaria tomentosa Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22560 Strychnos parvifolia Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26547 Uncaria tomentosa Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22560 Strychnos parvifolia Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22475.1 Brachylaena discolor var. rotundata Varieties Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22818 Acritopappus confertus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25311 Guettarda platypoda Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO21220 Pulicaria uliginosa Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1044 Individual protein DNA topoisomerase II alpha Homo sapiens IC50 > 250000.0 nM PMID[20371180]
NPT143 Individual protein DNA topoisomerase I Homo sapiens IC50 > 250000.0 nM PMID[20371180]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell line HeLa Homo sapiens MNCC = 100.0 ug ml-1 PMID[2553871]
NPT2517 Organism Human rhinovirus 1B Human rhinovirus 1B Activity = 50.0 % PMID[2553871]
NPT2516 Organism Vesicular stomatitis Indiana virus Vesicular stomatitis Indiana virus MIC50 = 40000.0 nM PMID[2553871]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC30397 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.975 High Similarity NPC235841
0.975 High Similarity NPC297208
0.8966 High Similarity NPC124296
0.8333 Intermediate Similarity NPC607754
0.7209 Intermediate Similarity NPC274507
0.6526 Remote Similarity NPC211798
0.6495 Remote Similarity NPC108748
0.6421 Remote Similarity NPC473481
0.6058 Remote Similarity NPC258885
0.5698 Remote Similarity NPC60755
0.5698 Remote Similarity NPC77099
0.5673 Remote Similarity NPC475171
0.5532 Remote Similarity NPC484195
0.5361 Remote Similarity NPC606107
0.5327 Remote Similarity NPC75417
0.5315 Remote Similarity NPC114484
0.5283 Remote Similarity NPC157868
0.5253 Remote Similarity NPC31839
0.5229 Remote Similarity NPC40775
0.5229 Remote Similarity NPC159309
0.5229 Remote Similarity NPC86222
0.5204 Remote Similarity NPC57362
0.5185 Remote Similarity NPC192791
0.5146 Remote Similarity NPC214484
0.5114 Remote Similarity NPC473242
0.5114 Remote Similarity NPC290690
0.5104 Remote Similarity NPC473844
0.5091 Remote Similarity NPC251768
0.5048 Remote Similarity NPC48499
0.5045 Remote Similarity NPC475591
0.5045 Remote Similarity NPC236870
0.5044 Remote Similarity NPC281148

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC30397 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data